Nephrogenic diabetes insipidus (lithium-induced)
Water balance · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Renal resistance to vasopressin from chronic lithium therapy, causing polyuria, polydipsia and risk of hypernatraemic dehydration if water access is limited.
Red flags
- Severe hypernatraemia
- Reduced conscious level
- Inability to access water
- Concurrent lithium toxicity
Assessment
Differential diagnosis
- Central diabetes insipidus
- Primary polydipsia
- Osmotic diuresis (hyperglycaemia)
- Hypercalcaemia-related DI
- Post-obstructive diuresis
Investigations
- Serum sodium and osmolality
- Urine osmolality (inappropriately dilute)
- U&E, calcium, glucose
- Lithium level
- Fluid balance and urine output
Management
- Assess hydration and sodium
- Ensure adequate access to water / free water replacement
- Correct hypernatraemia at a safe rate
- Review and (with psychiatry) consider reducing/stopping lithium
- Consider thiazide / amiloride (specialist, paradoxical benefit)
- Endocrinology / nephrology and psychiatry input
Drugs & doses
Free water / hypotonic fluids (careful rate)
Amiloride or thiazide (specialist)
Review lithium with psychiatry
Disposition
Admit if symptomatic hypernatraemia; specialist input.
Complications & pitfalls
- Hypernatraemic dehydration
- Neurological injury from rapid correction
- Persistent DI despite stopping lithium
Exam pearls
- Correct hypernatraemia slowly to avoid cerebral oedema.
- Amiloride can reduce lithium uptake and improve the concentrating defect.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.